Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.2 was added; notice about government funding lapse was removed and Revision: v3.4.1 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check35 days agoChange DetectedA site-wide notice about government funding was added and release notes were updated to revision v3.4.1. The previous note for v3.4.0 was removed.SummaryDifference1.0%

- Check43 days agoChange DetectedAdded a glossary toggle and No FEAR Act Data text, and updated the site revision to v3.4.0, while the previous No FEAR Act Data note and revision v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page shows a new revision version (v3.3.4) replacing the previous v3.3.3, indicating a minor update to the system.SummaryDifference0.1%

- Check78 days agoChange DetectedFooter/site changelog updated to Revision: v3.3.3 and removal of HHS Vulnerability Disclosure; no impact on study details or posted results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check107 days agoChange DetectedThe site version was updated from v3.2.0 to v3.3.2. This appears to be a backend or UI update that does not modify the study results or page content.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.